We see a future where we’re able to stop disease before it starts.

Help us combat cancer's survival strategy

Resistance to treatment is arguably the major issue facing patients with advanced cancers. Read about our latest breakthroughs and donate today to help us explore life-changing research.

Garvan eCard in lieu of a gift

Our donation gift eCards are now available. Make a donation to medical science on someone's else's behalf — and help create a brighter future for everyone

Disease: at some point we all have to face it

At Garvan, we see a future where disease can be stopped before it starts. It’s within reach.

Genome sequencing success for severe autoimmune condition

A four-year-old girl with a painful and rare immune disorder received life-changing targeted therapy, following whole genome sequencing at Garvan.

Garvan's annual breast cancer symposium

Hear about our significant advances in new treatments, drug resistance and metastasis, as well as new clinical trials. Join us for a free virtual breast cancer seminar on Zoom.

• Date: Friday, 23 October 2020
  Time: 10-11am
• Registration is essential.

Leave a gift in your Will

Leaving a bequest will serve to honour your memory and be a legacy of lasting hope for future generations.

Help solve cancer with DreamLab

DreamLab is an award-winning app that harnesses the processing power of smartphones to complete research faster. Download the app from the AppStore or Google Play and start fighting cancer tonight. 

Become a Partner for Discovery

Your regular donation will help us make amazing discoveries for a future where people live longer, healthier lives and disease can be truly manageable.

Purchase a gift that gives back

Purchase your Paspaley Kimberley Bracelet today. Paspaley donates 25 percent from each bracelet sold to Garvan’s cancer research, helping scientists change the lives of people living with rare and less common cancer.

Australian Polygenic Risk Symposium

The inaugural Australian Polygenic Risk Symposium will run from 18-19 November 2019 at the Garvan Institute of Medical Research in Sydney.